期刊文献+
共找到965篇文章
< 1 2 49 >
每页显示 20 50 100
Use of thyroglobulin as a tumour marker 被引量:2
1
作者 Buddhike Sri Harsha Indrasena 《World Journal of Biological Chemistry》 CAS 2017年第1期81-85,共5页
It is worthwhile to measure serum thyroglobulin(TG) level in thyroid cancer before subjecting patients to surgery for two reasons. Firstly, if the level is high, it may give a clue to the local and metastatic tumour b... It is worthwhile to measure serum thyroglobulin(TG) level in thyroid cancer before subjecting patients to surgery for two reasons. Firstly, if the level is high, it may give a clue to the local and metastatic tumour burden at presentation; secondly, if the level is normal,it identifies the patients who are unlikely to show rising TG levels in the presence of thyroid cancer. Those who have high serum TG before surgery will show up recurrence as rising serum TG during the postoperative period. Those who do not have high serum TG before surgery will not show up rising serum TG in the presence of recurrent disease. In the latter situation, normal TG level gives only a false reassurance regarding recurrence of disease. Nevertheless, rising serum TG during the postoperative period must be interpreted cautiously because this could be due to the enlargement of noncancerous residual thyroid tissue inadvertently left behind during surgery. 展开更多
关键词 thyroglobulin Thyroid cancer Recurrent thyroid cancer Anti-thyroglobulin antibodies Tumour marker
暂未订购
Serial stimulated thyroglobulin measurements are more specific for detecting distant metastatic differentiated thyroid cancer before radioiodine therapy 被引量:16
2
作者 Teng Zhao Jun Liang +2 位作者 Tianjun Li Wen Gao Yansong Lin 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2017年第3期213-222,共10页
Objective: Preablative stimulated thyroglobulin (ps-Tg) has the potential to be used in identifying distant metastatic differentiated thyroid carcinoma (DM-DTC), but its single level can be affected by remnant thyroid... Objective: Preablative stimulated thyroglobulin (ps-Tg) has the potential to be used in identifying distant metastatic differentiated thyroid carcinoma (DM-DTC), but its single level can be affected by remnant thyroid tissue and thyrotropin (TSH). The objective of this retrospective study was to evaluate the value of serial ps-Tg measurements in identifying DM-DTC specifically. Methods: A total of 317 DTC patients with serial measurements of ps-Tg, TSH and anti-Tg antibody were divided into M1 (n=72) and M0 (n=245) according to the presence of distant metastasis (DM) or not. The initial psTg measurement, with a corresponding TSH exceeding 30 mu IU/mL, was marked as Tg1, and ps-Tg measured right before radioactive iodine (RAI) therapy was defined as Tg2, with a median interval of 8 days. Delta Tg denotes Tg2-Tg1, and Delta TSH denotes TSH2-TSH1. Tg1, Tg2, Delta Tg, and Delta Tg/Delta TSH were tested for efficacy in identifying DM-DTC using receiver operating characteristic (ROC) curve analysis, and further compared with chest computed tomography (CT) and posttreatment whole-body RAI scan (RxWBS). Results: Compared with single ps-Tg measurement (Tg1 or Tg2), both Delta Tg and Delta Tg/Delta TSH were more narrowly distributed around zero in the M0 group, which made their distribution in the M1 group more distinguished in a relatively dispersed way. Delta Tg/Delta TSH manifested a higher accuracy (88.64%) and specificity (90.20%) in identifying DM-DTC than Tg1 or Tg2 measurements, with a much higher specificity than chest CT (90.20% vs. 66.00%) and a much higher sensitivity than RxWBS (83.33% vs. 61.11%). Conclusions: Serial ps-Tg measurements even over as short an interval as 8 days hold incremental value in identifying DM-DTC. Delta Tg/Delta TSH is a specific early biochemical marker for DM-DTC. 展开更多
关键词 Neoplasm metastasis thyroid cancer thyroglobulin iodine radioisotopes
暂未订购
Serum Thyroglobulin——A Sensitive Biomarker of Iodine Nutrition Status and Affected by Thyroid Abnormalities and Disease in Adult Populations 被引量:4
3
作者 DU Yang GAO Yan Hui +3 位作者 FENG Zhuo Ying MENG Fan Gang FAN Li Jun SUN Dian Jun 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2017年第7期508-516,共9页
Objective To evaluate the usefulness of the thyroglobulin (Tg) level in adults as a nutritiona biomarker of iodine status and to identify the factors related to the serum Tg level. Methods A cross-sectional study wa... Objective To evaluate the usefulness of the thyroglobulin (Tg) level in adults as a nutritiona biomarker of iodine status and to identify the factors related to the serum Tg level. Methods A cross-sectional study was conducted in adult populations of areas differing in iodine nutrition from three provinces (Autonomous Region) in China. Serum levels of thyroid hormones and Tg as well as thyroid autoantibodies were measured. The thyroid volume and nodule were measured by ultrasound. A multivariate linear regression analysis was used to assess iodine intake and other indeterminate factors associated with the serum Tg level. Results A total of 573 adults were recruited for this study. The serum Tg levels differed significantly among the three groups (22.27 ~g/L, 9.73 pg/L and 15.77 pg/L in the excess, more-than-adequate, and deficient groups, respectively). The results of multivariate linear regression analysis indicate that excess and deficient iodine intake, goiter, thyroid nodule, hypothyroidism are significantly related with higher Tg level, and TgAb positivity is significantly related with lower serum Tg. Conclusion The serum Tg level reflects abnormal thyroid function and is a sensitive functiona biomarker of iodine nutrition status. 展开更多
关键词 High iodine Iodine deficiency thyroglobulin
暂未订购
Comparison of Thyroglobulin and Thyroid Function in Pregnant Women between Counties with a Median Urinary Iodine Concentration of 100-149 μg/L and 150-249 μg/L 被引量:4
4
作者 CHEN Di Qun YE Ying +7 位作者 WU Jia Ni LAN Ying WANG Mu Hua WU Xiao Yan HE Meng WANG Li Jin ZHENG Xin Yi CHEN Zhi Hui 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2023年第10期917-929,共13页
Objective This study explored whether thyroglobulin and thyroid disease prevalence rates were higher in pregnant Chinese women with a median urinary iodine concentration of 100-149μg/L,compared with those with a medi... Objective This study explored whether thyroglobulin and thyroid disease prevalence rates were higher in pregnant Chinese women with a median urinary iodine concentration of 100-149μg/L,compared with those with a median urinary iodine concentration of 150-249μg/L maintained through sustainable universal salt iodization.Methods This was a cross-sectional study in which 812 healthy pregnant women were enrolled to collect samples of their household edible salt,urine,and blood during their routine antenatal care in the18 counties in Fujian Province,China.The levels of salt iodine concentration,urinary iodine concentration(UIC),free triiodothyronine(FT3),free thyroid hormone(FT4),thyroid-stimulating hormone(TSH),thyroglobulin(Tg),thyroid peroxidase antibody and thyroglobulin antibody were assessed during the routine antenatal care visits.Results The median UIC(m UIC)in pregnant women was 130.8μg/L(interquartile range=91.5-198.1μg/L)in the counties with an m UIC of 100-149μg/L(Group I),and 172.0μg/L(interquartile range=123.5-244.4μg/L)in the counties with an m UIC of 150-249μg/L(Group II).Goiter prevalence and thyroid nodule detection rates showed no difference between Group I and Group II(P>0.05).Except for FT4 values,the TSH,FT4,FT3,Tg and Tg values>40(μg/L)and the thyroid diseases prevalence rate(TDR)showed no significant differences between Group I and Group II(P>0.05),whether or not iodine supplementation measures were taken.Conclusion Compared with an m UIC of 150-249μg/L,not only there was no difference in thyroid morphology,but also the Tg value,rate of Tg values>40μg/L,and TDR were not higher in pregnant women in the counties with an m UIC of 100-149μg/L achieved through sustainable universal salt iodization in Fujian Province,China. 展开更多
关键词 Pregnant women Urinary iodine concentration thyroglobulin Thyroid dysfunction
暂未订购
Value of thyroglobulin combined with ultrasound-guided fine-needle aspiration cytology for diagnosis of lymph node metastasis of thyroid carcinoma 被引量:2
5
作者 Liu-Yang Zhang Yong Chen Ya-Zhou Ao 《World Journal of Clinical Cases》 SCIE 2022年第2期492-501,共10页
BACKGROUND Surgery for thyroid carcinoma offers a good prognosis;however,cervical lymph node metastasis may occur in the early stage.An effective diagnostic method can accurately guide clinical surgical planning and t... BACKGROUND Surgery for thyroid carcinoma offers a good prognosis;however,cervical lymph node metastasis may occur in the early stage.An effective diagnostic method can accurately guide clinical surgical planning and the scope of lymph node dissection,ultimately improving patient prognosis.AIM To explore the diagnostic value of fine-needle aspiration of thyroglobulin(FNATg)combined with ultrasound(US)-guided fine-needle aspiration cytology for cervical lymph node metastasis in thyroid carcinoma.METHODS We enrolled 209 pathologically confirmed thyroid carcinoma patients who visited our hospital between Jan 2017 and Dec 2020.Patients were tentatively diagnosed with cervical lymph node enlargement using preoperative US.They underwent US-guided fine-needle aspiration cytology and FNA-Tg.The value of single and combined application of the two methods for the diagnosis of cervical lymph node metastasis was calculated.The factors affecting FNA-Tg for diagnosis were analyzed using univariate and multivariate methods.RESULTS FNA-Tg values were significantly higher among patients with positive cervical lymph node metastasis.The sensitivity and specificity of US-guided fine-needle aspiration cytology,FNA-Tg,and US-guided fine-needle aspiration cytology+FNA-Tg were 85.48%and 90.59%,83.06%and 87.06%,and 96.77%and 91.76%,respectively.The area under the receiver operating characteristic curve for USguided fine-needle aspiration cytology,FNA-Tg,and the two combined,was 0.880,0.851,and 0.943,respectively.A long diameter/short diameter ratio<2,an insufficient number of acquired cells,a low serum thyroglobulin level,and an absence of typical metastatic US features increased the risk of cervical lymph node metastasis in thyroid carcinoma patients misdiagnosed using FNA-Tg.CONCLUSION The diagnostic value of FNA-Tg for detecting cervical lymph node metastasis is not high;however,combined with US-guided fine-needle aspiration cytology,it is significantly improved. 展开更多
关键词 Thyroid carcinoma Ultrasonic guidance Fine-needle aspiration cytology Lymph node puncture thyroglobulin DIAGNOSIS
暂未订购
Correlation analysis of serum thyroglobulin,thyroid-stimulating hormone levels,and thyroid-cancer risk in thyroid nodule surgery 被引量:3
6
作者 Jin-Hao Shuai Zhao-Fang Leng +1 位作者 Peng Wang Yi-Chi Ji 《World Journal of Clinical Cases》 SCIE 2023年第27期6407-6414,共8页
BACKGROUND Thyroglobulin(Tg)is one of the markers of thyroid cancer,and its concentration may be elevated in patients with malignant thyroid tumors.Thyroid-stimulating hormone(TSH)is secreted by the pituitary gland,wh... BACKGROUND Thyroglobulin(Tg)is one of the markers of thyroid cancer,and its concentration may be elevated in patients with malignant thyroid tumors.Thyroid-stimulating hormone(TSH)is secreted by the pituitary gland,which has a significant impact on thyroid gland function.Excessively high or low TSH levels may be associated with an increased risk of thyroid cancer.Thus,in-depth studies on the association of serum Tg and TSH levels with thyroid cancer risk in patients with thyroid nodules are warranted.This can help determine whether Tg and TSH levels can predict the degree of malignancy of thyroid nodules,which can in turn guide doctors in making accurate diagnoses and treatment decisions.Furthermore,such studies can provide more accurate diagnostic methods for thyroid nodules and help patients become aware of the presence of thyroid cancer as early as possible,thereby improving the success rate of treatment and prognosis.AIM To investigate the association of serum Tg and TSH levels with the risk of thyroid cancer in patients undergoing thyroid nodule surgery.METHODS The clinical data and laboratory examination results of 130 patients who underwent thyroid nodule surgery were retrospectively analyzed.Furthermore,their preoperative serum Tg and TSH levels were recorded.Histopathological examination conducted during follow-up revealed the presence of thyroid cancer.Correlation analysis were used to analyze the association of Tg and TSH levels with the risk of thyroid cancer.RESULTS Of the 130 patients,60 were diagnosed with thyroid cancer.Statistical analysis revealed a significant positive correlation between serum Tg levels and the risk of thyroid cancer(P<0.05).This suggests that high serum Tg levels are associated with an increased risk of thyroid cancer.However,no significant correlation was observed between serum TSH levels and the risk of thyroid cancer(P>0.05).CONCLUSION In patients who underwent thyroid nodule surgery,serum Tg levels exhibited a significant correlation with the risk of thyroid cancer but serum TSH levels did not.These findings suggest that serum Tg can serve as an important biomarker for assessing the risk of thyroid cancer in these patients. 展开更多
关键词 Thyroid nodule surgery Serum thyroglobulin Serum thyroid-stimulating hormone Thyroid cancer Risk correlation Prediction of thyroid nodules
暂未订购
Optimal Threshold of Stimulated Serum Thyroglobulin Level for ^(18)F-FDG PET/CT imaging in Patients with Thyroid Cancer
7
作者 柴红 张虎 +1 位作者 余永利 高云朝 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2017年第3期429-432,共4页
This study was to explore the optimal threshold of thyroid-stimulating hormone(TSH)-stimulated serum thyroglobulin(s-Tg) for patients who were to receive18F-fluorodeoxyglucose(18F-FDG) PET/CT scan owing to clinical su... This study was to explore the optimal threshold of thyroid-stimulating hormone(TSH)-stimulated serum thyroglobulin(s-Tg) for patients who were to receive18F-fluorodeoxyglucose(18F-FDG) PET/CT scan owing to clinical suspicion of differentiated thyroid cancer(DTC) recurrence but negative post-therapeutic 131I whole-body scan(131I-WBS). A total of 60 qualified patients underwent PET/CT scanning from October 2010 to July 2014. The receiver operating characteristic(ROC) curve analyses showed that s-Tg levels over 49 μg/L led to the highest diagnostic accuracy of PET/CT to detect recurrence, with a sensitivity of 89.5% and a specificity of 90.9%. Besides, bivariate correlation analysis showed positive correlation between s-Tg levels and the maximum standardized uptake values(SUVmax) of18F-FDG in patients with positive PET/CT scanning, suggesting a significant influence of TSH both on Tg release and uptake of18F-FDG. So, positive PET/CT imaging is expected when patients have negative 131I-WBS but s-Tg levels over 49 μg/L. 展开更多
关键词 18F-fluorodeoxyglucose(18F-FDG) positron emission tomography/computed tomography(PET/CT) differentiated thyroid cancer(DTC) post-therapeutic 131I whole-body scan(131I-WBS) serum thyroglobulin(Tg) thyroid-stimulating hormone(TSH)
暂未订购
Impact of Thyroglobulin on Survival and Prognosis of Differentiated Thyroid Cancer
8
作者 Hanan Ahmed Wahba Hend Ahmed El-Hadaad +2 位作者 Abeer Hussien Anter Alaa M. Wafa Ahmed Negm 《Journal of Cancer Therapy》 2018年第9期706-713,共8页
Proper assessment of risk factors contributes to the principle management of differentiated thyroid carcinoma post operatively. Aim of the study: to investigate the effect of Thyroglobulin (Tg) levels on prognosis tog... Proper assessment of risk factors contributes to the principle management of differentiated thyroid carcinoma post operatively. Aim of the study: to investigate the effect of Thyroglobulin (Tg) levels on prognosis together with other risk factors for Differentiated Thyroid Cancer (DTC). Patients and methods: Medical records of all patients with DTC presented to Clinical Oncology and Nuclear Medicine Department referred from Diabetes & Endocrine unit (Internal Medicine Hospital) and Surgery Department Mansoura University from 2011-2016 were retrospectively reviewed. Patients with distant metastasis or who lost follow-up were excluded. So data of 220 patients were analyzed. Data collected included pre-surgical assessment, also surgical interference either total or near total thyroidectomy with or without lymph node neck dissection were reviewed. Different prognostic factors that affect progression free survival (PFS) include age, umorsize, ymph node status, ex, multifocality, capsular infiltration, vascular invasion and Tg level were evaluated through multivariate analysis. Results: Most of the patients included were <45 years (69.1%). Incidence of the disease was higher in female (80%) with papillary type predominance (80.9%). About 59.5% of cases presented with tumor size ≤ 2 cm and multifocality was reported in 13.6%. While 30% had lymph node metastasis, 11% had vascular invasion. Capsular infiltration was observed in 15% and most of them showed Tg level ≤ 10 ng/ml (68.2%). About 70% received ablative radioiodine. The 5-year Progression Free Survival (PFS) was 85%. On multivariate analysis of variable prognostic factors on PFS, we found that tumor size, age, lymph node status, capsular infiltration, Tg level and vascular invasion significantly affected PFS (P = 0.01, 0.005, 0.004, 0.005, 0.02, 0.003) respectively. While sex, pathological type and multifocality were not (P = 0.9, 0.4, 0.6) respectively. Conclusion: Postoperative Tg level is a statistically significant prognostic factor together with other risk factors. 展开更多
关键词 thyroglobulin THYROID CANCER DIFFERENTIATED THYROID CANCER Risky Factors
暂未订购
Differentiated Thyroid Cancer with Thyroglobulin Elevation and Negative Iodine Scintigraphy (TENIS Syndrome)
9
作者 Raja Sfar Tarek Kamoun +8 位作者 Manel Nouira Hamza Regaieg Nouha Ammar Hela Charfi Achraf Bahloul Maha Ben Fredj Kaouther Chatti Mohsen Guezguez Habib Essabbah 《International Journal of Otolaryngology and Head & Neck Surgery》 2014年第4期149-153,共5页
Background and Objectives: Following the initial management, some patients with differentiated thyroid cancer (DTC) develop a state of high thyroglobulin (Tg) and Negative Iodine Scintigraphy. The predisposing factors... Background and Objectives: Following the initial management, some patients with differentiated thyroid cancer (DTC) develop a state of high thyroglobulin (Tg) and Negative Iodine Scintigraphy. The predisposing factors and outcome of this condition are unclear. In this study, our objectives were to analyze the characteristics of patients with high Tg level and negative Iodine scintigraphy and to determine the predictive factors for development of high Tg and negative scintigraphy. Patients and Methods: Retrospective study of 34 patients undergoing treatment for DTC, followed in the Nuclear Medicine department of the University Hospital—Sahloul Sousse between 1990 and 2006 and having a high Tg and negative Iodine scintigraphy. Fourteen patients had Tg between 2 and 10 ng/ml, 16 had Tg between 11 and 100 ng/ml and 4 patients had Tg more than 100 ng/ml. Results: There were 25 women and 9 men. The mean age was 51.65 years. In 94.1% of cases, the tumor was papillary carcinoma. Follicular tumors accounted for only 5.9%. The mean nodule size was3.26 cm. Capsular invasion was seen in 47.1% cases. The locoregional invasion was found in 35.3%. The lymph node extension was found in 84.8% of patients having lymph node surgery. Lymph node involvement was observed in 92.8% of patients with papillary cancer but it was found in 7.2% of patients with follicular cancers. Lymph node invasion was unilateral in 28.6% (N1a) and bilateral, contralateral or mediastinal in 71.4% (N1b). Initial level of Tg was as follows: 7 patients had Tg between 2 and 10 ng/ml, 14 patients had Tg between 11 and 100 ng/ml and 12 had Tg more than 100 ng/ml. The mean number of radioactive Iodine cure was 11.08 for patients with Tg more than 100 ng/ml with a significant difference (P = 0.001). Conclusion: Among epidemiological, pathological and clinical characteristics, lymph node invasion is the most frequent parameter found in patients with a DTC with high Tg level and negative Iodine scintigraphy. 展开更多
关键词 DIFFERENTIATED THYROID Cancer thyroglobulin IODINE SCINTIGRAPHY TENIS SYNDROME
暂未订购
Anti-Thyroglobulin IgG in Therapeutic Immunoglobulins: A Reactivity Bias in IgG4 Subclass
10
作者 Sonia Néron Annie Roy +1 位作者 Nathalie Dussault Caroline Philipeau 《Open Journal of Immunology》 2014年第3期68-75,共8页
Therapeutic immunoglobulins are used in the treatment of immunodeficiencies as well as several autoimmune and inflammatory diseases. These intravenous immunoglobulins (IVIg) represent the healthy human IgG repertoire,... Therapeutic immunoglobulins are used in the treatment of immunodeficiencies as well as several autoimmune and inflammatory diseases. These intravenous immunoglobulins (IVIg) represent the healthy human IgG repertoire, which can be reactive for both self and non-self antigens. A better characterization of IVIg’s repertoire is an important aspect to enable its effective utilization as an immunomodulatory treatment. In this study we have investigated the reactivity of IgG1, IgG2, IgG3 and IgG4 present in IVIg for a small selection of antigens, including actin, DNA, ferritin and thyroglobulin. We observed that two commercial preparations of therapeutic immunoglobulins contain very high reactivity for thyroglobulin, which was predominantly detected by IgG4. Since IgG4 antibodies can have immunomodulatory properties, these result suggest that these anti-thyroglobulin may have a role in the IVIg treatment of autoimmune disease characterized by high avidity for anti-thyroglobulin antibodies such as Hashimoto’s disease. 展开更多
关键词 IGG4 Anti-thyroglobulin Human Intravenous IMMUNOGLOBULIN
暂未订购
Correlation of serum thyroglobulin and anti-thyroglobulin antibody levels with pulmonary metastasis and bone metastasis in patients with thyroid cancer
11
作者 Jun-Jun Tian Ran Tao +2 位作者 Yin-Feng Shen Shao-You Xia Chen Li 《Journal of Hainan Medical University》 2017年第12期101-104,共4页
Objective:To study the correlation of serum thyroglobulin (TG) and anti-thyroglobulin antibody (TGAb) levels with pulmonary metastasis and bone metastasis in patients with thyroid cancer.Methods: Patients with thyroid... Objective:To study the correlation of serum thyroglobulin (TG) and anti-thyroglobulin antibody (TGAb) levels with pulmonary metastasis and bone metastasis in patients with thyroid cancer.Methods: Patients with thyroid cancer who underwent surgical resection in our hospital were selected as the research subjects, and the patients without distant metastasis, with pulmonary metastasis and with bone metastasis were screened and enrolled in non-metastasis group, pulmonary metastasis group and bone metastasis group respectively. Serum was collected to determine the levels of TG and TGAb, and metastatic lesion tissue was collected to determine the expression proliferation-related molecules Bcl-2, Skp-2, caspase-3 and p27 as well as invasion molecules S100A4, MMP2, MMP13, SATB1 and Vimentin.Results: The positive rates of serum TGAb and TG of pulmonary metastasis group and bone metastasis group were significantly higher than those of non-metastasis group;S100A4, MMP2, MMP13, SATB1, Vimentin, Bcl-2 and Skp-2 mRNA contents in metastatic lesions of patients with positive serum TG and TGAb were significantly higher than those of patients with negative serum TG and TGAb while caspase-3 and p27 mRNA contents were significantly lower than those of patients with negative serum TG and TGAb.Conclusion:The increase of serum TG and TGAb contents is associated with the pulmonary metastasis and bone metastasis after thyroid carcinoma surgery, and has promoting effect on the proliferation and invasion of cancer cells in metastatic lesions. 展开更多
关键词 THYROID cancer thyroglobulin METASTASIS Proliferation INVASION
暂未订购
Struma ovarii associated with increased serum thyroglobulin
12
作者 Na Su Fei Ji +2 位作者 Yang Cao Dan Wang Meng Yang 《iRADIOLOGY》 2023年第4期397-398,共2页
A 36-year-old woman with papillary thyroid cancer was diagnosed with a right ovarian mass ultrasono-graphically 2 years earlier.The mass increased in size gradually,and serum thyroglobulin(Tg)levels increased simultan... A 36-year-old woman with papillary thyroid cancer was diagnosed with a right ovarian mass ultrasono-graphically 2 years earlier.The mass increased in size gradually,and serum thyroglobulin(Tg)levels increased simultaneously to 1002.36 ng/mL;cancer antigen 125 levels remained normal.Preoperative ul-trasonography demonstrated a right ovarian mass(6.3×5.2×3.8 cm)(Figure 1a,Video S1)consisting of homogeneous solid components and multiple follicles(Figure 1b).The mass exhibited high vascularity on color Doppler(Figure 1c).These features highly sug-gested struma ovarii(SO)and were consistent with magnetic resonance imaging findings.Single-port lapa-roscopic right adnexectomy was performed,with ascites seen in the pouch of Douglas(Figure 1d).The right ovary was fully occupied by a tumor(Figure 1e)con-taining grayish-brown gelatinous material(Figure 1f).Pathological examination confirmed SO.The serum Tg level decreased to normal 2 months after laparoscopy,which suggested SO as an extraglandular source of Tg. 展开更多
关键词 struma ovarii thyroglobulin ULTRASONOGRAPHY
暂未订购
Postoperative Stimulated Thyroglobulin Level and Recurrence Risk Stratification in Differentiated Thyroid Cancer 被引量:28
13
作者 Xue Yang Jun Liang +4 位作者 Tian-Jun Li Ke Yang Dong-Quan Liang Zhuang Yu Yan-Song Lin 《Chinese Medical Journal》 SCIE CAS CSCD 2015年第8期1058-1064,共7页
Background: Postoperative preablative stimulated thyroglobulin (ps-Tg) has been evaluated in predicting prognosis and success of ablation regarding differentiated thyroid cancer (DTC); however, its relationship w... Background: Postoperative preablative stimulated thyroglobulin (ps-Tg) has been evaluated in predicting prognosis and success of ablation regarding differentiated thyroid cancer (DTC); however, its relationship with recurrence risk and radioiodine decision-making remains uncertain, especially in Chinese DTC patients. We aimed to evaluate the association between ps-Tg and recurrence risk stratification in DTC, to provide incremental values for ps-Tg in postoperative assessment and radioiodine management. Methods: Seven hundred and seven patients with DTC were included; low-risk (L; n = 90), intermediate-risk (I; n = 283), and high-risk (H; n = 334, 117 with distant metastasis [M 1 ]) patients were divided according to recurrence risk stratification. The M 1 group was further analyzed regarding evidence of metastasis. Cut-off values of ps-Tg were obtained using receiver operating characteristic analysis. Results: Patients with more advanced disease at initial risk stratification were more likely to have higher ps-Tg levels (I vs. L: P 〈 0.05; H vs. 1: P 〈 0.001; H vs. L: P 〈 0.001). The corresponding cut-off value of ps-Tg for distinguishing sensitivity and specificity in each of the two groups was 2.95 ng/ml (1 vs. L: 61.5%, 63.3%), 29.5 ng/ml (H vs, I: 41.9%, 92.6%), 47.1 ng/ml (M1 vs. M0 in the H group: 79.5%, 88.9%) and 47.1 ng/ml (MI vs. M0 in all patients: 79.5%, 93.7%). With the cut-offvalue at 47.1 ng/ml, ps-Tg was the only factor that could be used to identify distant metastases, and consequently if measured before radioiodine therapy would prevent 10.26% of patients with M1 from undertreatment, Conclusions: Ps-Tg, as an ongoing reassessment marker, favors differential recurrence risk grading and provides incremental values for radioiodine treatment decision-making. 展开更多
关键词 Ablation Differentiated Thyroid Carcinoma: Radioiodine Therapy Recurrence Risk Stratification: thyroglobulin
原文传递
^(131)I治疗对ps-Tg水平<10 ng/ml DTC患者的疗效与影响因素分析
14
作者 武文婷 张潇宇 +3 位作者 郭晓雅 邵洁琼 吴力翔 陆克义 《国际放射医学核医学杂志》 2026年第2期69-76,共8页
目的探讨^(131)I治疗对术后刺激性甲状腺球蛋白(ps-Tg)水平<10 ng/ml分化型甲状腺癌(DTC)患者的疗效与影响因素。方法采用回顾性队列研究,收集2021年1月至2022年12月于山西医科大学第一医院行^(131)I治疗的190例中高危DTC患者的临床... 目的探讨^(131)I治疗对术后刺激性甲状腺球蛋白(ps-Tg)水平<10 ng/ml分化型甲状腺癌(DTC)患者的疗效与影响因素。方法采用回顾性队列研究,收集2021年1月至2022年12月于山西医科大学第一医院行^(131)I治疗的190例中高危DTC患者的临床资料、影像资料和组织病理学检查资料,其中男性61例、女性129例,年龄(44.5±10.4)岁,所有患者均行甲状腺全切或近全切术且ps-Tg<10 ng/ml[即^(131)I治疗前被评估为疗效满意(ER)或疗效不确切(IDR)]。^(131)I治疗前所有患者均行甲状腺^(99)Tc^(m)O_(4)^(-)显像,口服治疗剂量^(131)I后5~7 d行^(131)I治疗后全身显像(Rx-WBS)。根据动态疗效反应评估体系再将术后疗效满意(po-ER)组和术后疗效不确切(po-IDR)组患者各自分为经^(131)I治疗后ER(pt-ER)亚组和^(131)I治疗后疗效不满意(pt-nER)亚组。采用Spearman相关性分析评估甲状腺^(99)Tc^(m)O_(4)^(-)显像与^(131)I Rx-WBS评分间的相关性;采用Mann-Whitney U秩和检验、t检验、Fisher确切概率法或χ^(2)检验分析2组内pt-ER、pt-nER亚组间计量及计数资料的差异,将差异有统计学意义的指标纳入二元Logistic回归分析,并采用受试者工作特征(ROC)曲线确定预测疗效的最佳临界值。结果po-ER组136例(pt-ER亚组131例、pt-nER亚组5例)、po-IDR组54例(pt-ER亚组44例、pt-nER亚组10例)。po-ER和po-IDR 2组的随访末期疗效差异有统计学意义(χ^(2)=11.710,P=0.0006)。甲状腺^(99)Tc^(m)O_(4)^(-)显像在po-IDR组内的pt-ER亚组和pt-nER亚组间的差异有统计学意义(Fisher确切概率法,P=0.0004),^(131)I Rx-WBS评分在po-ER组内的pt-ER亚组和pt-nER亚组间的差异有统计学意义(Fisher确切概率法,P<0.05)。在po-ER组内,甲状腺^(99)Tc^(m)O_(4)^(-)显像结果与^(131)I Rx-WBS评分呈轻度相关(r=0.328,P=0.0005),且与甲状腺^(99)Tc^(m)O_(4)^(-)显像阴性组相比,阳性组患者中^(131)I Rx-WBS评分为3~4分的患者比例更高。在po-ER组内,pt-ER亚组和pt-nER亚组间仅T分期的差异有统计学意义(Fisher确切概率法,P<0.05);在po-IDR组内,pt-ER亚组和pt-nER亚组间仅ps-Tg水平的差异有统计学意义(Z=−2.784,P<0.05),年龄、性别、被膜受累、肿瘤多灶性、肿瘤最大径、N分期、复发危险分层、促甲状腺激素水平、首次^(131)I治疗剂量、尿碘水平在2亚组间的差异均无统计学意义(Z=−2.784~−0.201,t=−0.392~1.272,χ^(2)=0.000~0.188,Fisher确切概率法,均P>0.05)。二元Logistic回归分析显示,T分期不是影响po-ER组内患者^(131)I治疗疗效的独立危险因素(P>0.05)。ps-Tg水平是影响po-IDR组内患者^(131)I治疗疗效的独立危险因素(OR=1.596,95%CI=1.133~2.250,P=0.008)。ROC曲线分析显示,ps-Tg水平预测^(131)I治疗后疗效的最佳临界值为4.95 ng/ml、灵敏度为70%、特异度为77%、曲线下面积为0.784。结论对于ps-Tg水平<10 ng/ml的DTC患者,经^(131)I治疗后均可表现出良好的疗效反应,且多数为po-ER患者。 展开更多
关键词 碘放射性同位素 甲状腺球蛋白 分化型甲状腺癌 放射性核素治疗 治疗结果
原文传递
定时定量rhTSH刺激分化型甲状腺癌细胞对其Tg分泌、NIS表达及^(131)I摄取功能的影响
15
作者 尹雪 郑虹媛 +3 位作者 李宁 谭建 贾强 郑薇 《国际放射医学核医学杂志》 2026年第2期86-95,共10页
目的探讨重组人促甲状腺素(rhTSH)对分化型甲状腺癌细胞甲状腺球蛋白(Tg)分泌、钠碘同向转运体(NIS)表达及^(131)I摄取功能的影响。方法采用实时荧光定量聚合酶链式反应(RT-qPCR)筛选出KTC-1、TPC-1、BCPAP 3种人甲状腺乳头状癌细胞株... 目的探讨重组人促甲状腺素(rhTSH)对分化型甲状腺癌细胞甲状腺球蛋白(Tg)分泌、钠碘同向转运体(NIS)表达及^(131)I摄取功能的影响。方法采用实时荧光定量聚合酶链式反应(RT-qPCR)筛选出KTC-1、TPC-1、BCPAP 3种人甲状腺乳头状癌细胞株中促甲状腺激素受体(TSHR)基因表达水平最高的细胞株用于后续实验。以该细胞为研究对象,首先进行浓度效应实验[对照组(rhTSH浓度为0 ng/ml,记为N组),实验组(rhTSH浓度分别为50、100、200、300、500 ng/ml,依次记为R1组、R2组、R3组、R4组、R5组),各组均作用24 h]。然后,在确定最佳作用浓度的基础上,进行时间效应实验[实验组(最佳浓度rhTSH作用2、6、12、18、24 h),对照组(使用不含rhTSH的同等培养基培养2、6、12、18、24 h)]。采用蛋白质印迹法检测TSHR、NIS蛋白相对表达水平,酶联免疫吸附测定法(ELISA)检测细胞上清液中Tg的浓度,甲状腺功能测定仪检测细胞24 h^(131)I摄取率。2组间比较采用两独立样本t检验,多组间比较用单因素方差分析。结果BCPAP细胞的TSHR基因相对表达水平显著高于TPC-1细胞和KTC-1细胞,且差异均有统计学意义[2^(−ΔΔCT):(0.88±0.32)对(0.30±0.10)对(0.01±0.00),t=0.575、0.872,P=0.008、P<0.001],故选用BCPAP细胞作为后续实验细胞。(1)浓度效应实验中,R3组、R4组、R5组的Tg浓度均显著高于N组,差异均有统计学意义[(6.13±0.16)ng/ml对(5.39±0.28)ng/ml、(6.63±0.57)ng/ml对(5.39±0.28)ng/ml、(6.42±0.39)ng/ml对(5.39±0.28)ng/ml,t=4.015、3.367、3.701,P=0.016、0.028、0.021];R4组NIS蛋白相对表达水平显著高于N组、R1组、R2组、R3组、R5组,差异均有统计学意义[(1.02±0.22)对(0.30±0.01)对(0.46±0.02)对(0.59±0.01)对(0.70±0.01)对(0.83±0.01),t=9.769~27.959,均P≤0.001];R4组的^(131)I摄取计数明显高于N组、R1组、R2组、R3组,差异均有统计学意义[(1404.00±8.19)cmp对(1297.67±17.90)cmp对(1301.67±30.09)cmp对(1304.67±24.83)cmp对(1365.33±17.79)cmp,t=3.421~9.358,均P<0.05]。(2)时间效应实验中,300 ng/ml rhTSH作用24 h内可持续促进Tg分泌[(6.07±0.56)ng/ml对(5.66±0.51)ng/ml,t=2.124,P=0.043];在24 h时可显著提高NIS蛋白表达[(1.09±0.87)对(0.83±0.09),t=3.537,P=0.024]。实验组细胞在12~24 h内的^(131)I摄取率显著高于同期对照组[12 h:(1251.33±52.70)cmp对(1078.00±16.00)cmp、18 h:(1312.00±14.00)cmp对(1201.00±24.27)cmp、24 h:(1404.00±48.66)cmp对(1309.67±32.52)cmp,t=5.451、6.862、2.792,P=0.006、0.002、0.049]。结论300 ng/ml的rhTSH作用于BCPAP细胞24 h内能有效促进BCPAP细胞的Tg分泌、NIS蛋白表达及^(131)I摄取功能。 展开更多
关键词 甲状腺肿瘤 促甲状腺素 甲状腺球蛋白 分化型甲状腺癌 钠碘同向转运体
原文传递
超声影像组学联合血清球蛋白预测甲状腺乳头状癌中央区淋巴结转移的价值
16
作者 商留阳 王华 《黑龙江医药科学》 2026年第2期9-12,共4页
目的:基于超声影像组学特征和术前血清甲状腺球蛋白(Tg)水平,构建预测甲状腺乳头状癌(PTC)患者中央区淋巴结转移(CLNM)风险的联合模型。方法:选取2022年1月至2024年6月洛阳市中心医院经病理证实的PTC患者147例,其中CLNM阳性85例,阴性62... 目的:基于超声影像组学特征和术前血清甲状腺球蛋白(Tg)水平,构建预测甲状腺乳头状癌(PTC)患者中央区淋巴结转移(CLNM)风险的联合模型。方法:选取2022年1月至2024年6月洛阳市中心医院经病理证实的PTC患者147例,其中CLNM阳性85例,阴性62例。按7:3比例将患者随机分为训练组103例与测试组44例。所有患者术前检测血清Tg。在灰阶超声图像中勾画感兴趣区域(ROI),提取影像组学特征后采用最小绝对收缩和选择算子(LASSO)进行特征筛选,并计算每例患者的影像组学评分(RadScore)。分别建立血清Tg模型、影像组学模型及联合模型,采用受试者工作特征(ROC)曲线评估各模型预测CLNM的性能。结果:联合模型在训练组和测试组中的曲线下面积(AUC)分别为0.927(95%CI:0.873~0.982)和0.872(95%CI:0.761~0.982),优于血清Tg模型(0.789、0.746)和影像组学模型(0.862、0.760)。临床决策曲线分析(DCA)显示联合模型具有较高临床适用性。结论:基于超声影像组学特征联合术前血清Tg水平构建的模型可有效预测PTC患者CLNM风险,性能优于单一指标模型。 展开更多
关键词 甲状腺乳头状癌 超声影像组学 甲状腺球蛋白 中央区淋巴结转移 预测模型
暂未订购
Conservative Treatment of Fetal Goitrous Hypothyroidism Due to Thyroglobulin Mutations:A Case Report and Literature Review
17
作者 Shiping Liu Wei Bai +7 位作者 Ying Gao Chunyan Shi Lixin Fan Junya Chen Jian Shi Weije Sun Xinlin Hou Huixia Yang 《Maternal-Fetal Medicine》 CSCD 2023年第3期182-186,共5页
With the advances in fetal medicine,there will be more cases of congenital hypothyroidism(CH)diagnosed in the fetal period.However,there is no consensus on the management protocol.We present a successful case of conse... With the advances in fetal medicine,there will be more cases of congenital hypothyroidism(CH)diagnosed in the fetal period.However,there is no consensus on the management protocol.We present a successful case of conservatively managed fetal goitrous hypothyroidism due to compound heterozygous TG mutations.Goiter was observed in a fetus at 23 weeks of gestation.Because there was no evidence of transplacental passage of antithyroid antibody and drugs,iodine overload,and iodine deficiency,the fetus was highly suspected to have CH.Considering the potential risks of amniocentesis/cordocentesis,and lack of available parenteral levothyroxine in China,the fetus was closely monitored thereafter.A male neonate was delivered vaginally without complications at 39 weeks of gestation.We verified severe hypothyroidism in the infant and immediately initiated levothyroxine therapy.His growth and mental development were normal at the age of 8 month.Whole-exome sequencing showed that the neonate had two compound heterozygous mutations in the TG gene.We also performed a literature review of the prognosis of postnatal treatment of CH due to TG mutations and the result showed that postnatal treatment of CH due to TG mutations has a favorable prognosis.However,further prospective studies are warranted to verify this conclusion. 展开更多
关键词 thyroglobulin Gene mutations Fetal hypothyroidism
原文传递
碘131治疗后甲状腺球蛋白抗体动态变化对分化型甲状腺癌结构性进展的预测价值
18
作者 王秀娟 田耕荣 +2 位作者 武文杰 冯玙 刘慧芳 《临床和实验医学杂志》 2026年第1期97-101,共5页
目的探讨碘131(^(131)I)治疗后患者甲状腺球蛋白抗体(TgAb)的动态变化对分化型甲状腺癌(DTC)结构性进展的预测价值。方法回顾性纳入2021年12月至2024年12月山西省中医院收治的DTC患者106例,所有患者均为首次接受^(131)I治疗。根据是否发... 目的探讨碘131(^(131)I)治疗后患者甲状腺球蛋白抗体(TgAb)的动态变化对分化型甲状腺癌(DTC)结构性进展的预测价值。方法回顾性纳入2021年12月至2024年12月山西省中医院收治的DTC患者106例,所有患者均为首次接受^(131)I治疗。根据是否发生DTC结构性进展,分为结构性进展组(n=22)与非结构性进展组(n=84)。检测患者治疗前及治疗后3个月、12个月、24个月、36个月的血清TgAb。通过影像学检查进行疾病监测。分析DTC结构性进展的危险因素,采用受试者操工作特征(ROC)曲线分析TgAb变化趋势的最佳截断值,评估其在DTC结构性进展中的预测作用。结果结构性进展组患者≥55岁(54.55%)、TgAb治疗后36个月下降幅度≥50%(72.73%)占比均高于非结构性进展组(27.38%、26.19%),差异均有统计学意义(P<0.05)。两组患者在治疗后不同时间点(3个月、12个月、24个月、36个月)TgAb变化幅度呈动态下降趋势,差异均有统计学意义(P<0.05);治疗后3个月(下降≥50%)、12个月(下降≥65%)、24个月(下降≥70%)、36个月(下降≥75%)时:非结构性进展组占比分别为69.05%、75.00%、82.14%、72.62%,均显著高于结构性进展组(22.73%、18.18%、13.64%、27.27%),差异均有统计学意义(P<0.05)。多因素Cox回归分析结果显示:年龄≥55岁、治疗后36个月TgAb下降幅度≥50%为DTC结构性进展的独立危险因素。ROC曲线分析显示:最佳截断值随观察时间点后移而提高,依次为治疗后3个月下降≥50%(AUC=0.732)、治疗后12个月下降≥65%(AUC=0.784)、治疗后24个月下降≥70%(AUC=0.843)及治疗后36个月下降≥75%(AUC=0.733)。结论^(131)I治疗后TgAb的动态变化对DTC结构性进展具有重要的预测价值。年龄≥55岁、治疗后36个月TgAb下降幅度<50%是DTC发生结构性进展的独立危险因素。此外,TgAb在治疗后不同时间点的下降幅度(治疗后3个月≥50%、治疗后12个月≥65%、治疗后24个月≥70%、治疗后36个月≥75%)可有效区分疾病进展风险。监测TgAb动态变化有助于早期识别高危患者,为个体化随访与管理提供依据。 展开更多
关键词 甲状腺肿瘤 碘131治疗 DTC结构性进展 甲状腺球蛋白抗体
暂未订购
孕早期甲状腺功能指标对孕妇发生妊娠期糖尿病风险的临床价值分析
19
作者 余蓓蓓 武培 +2 位作者 周婷婷 李凤启 袁二凤 《安徽医药》 2026年第1期92-95,共4页
目的探讨孕早期甲状腺功能指标对孕妇妊娠期糖尿病(GDM)的临床价值。方法选取2021年3月至2022年9月周口市妇幼保健院孕检孕妇195例为研究对象,于妊娠8~12周行甲状腺功能检查,于妊娠24~25周行75 g葡萄糖耐量测试(OGTT)检查,依据OGTT结果... 目的探讨孕早期甲状腺功能指标对孕妇妊娠期糖尿病(GDM)的临床价值。方法选取2021年3月至2022年9月周口市妇幼保健院孕检孕妇195例为研究对象,于妊娠8~12周行甲状腺功能检查,于妊娠24~25周行75 g葡萄糖耐量测试(OGTT)检查,依据OGTT结果分为GDM组、对照组(孕妇糖耐量正常)。收集孕妇一般资料,检测血清甲状腺功能指标[促甲状腺素(TSH)、游离三碘甲状腺原氨酸(FT3)、游离甲状腺素(FT4)、甲状腺球蛋白抗体(TG-Ab)、甲状腺过氧化物酶抗体(TPO-Ab)]水平。对上述临床资料进行单因素分析,将差异有统计学意义的指标纳入logistic回归模型,分析孕妇发生GDM风险的影响因素,采用受试者操作特征曲线(ROC曲线)评估甲状腺功能指标对GDM的临床效能。结果GDM组血清FT3(3.60±0.87)pmol/L、FT4(5.02±1.53)pmol/L低于对照组[(4.54±1.02)pmol/L、(9.37±2.24)pmol/L],血清TSH(3.36±1.04)mU/L、TPO-Ab(4892.52±1221.62)IU/L、TG-Ab(3841.65±1011.54)IU/L及糖尿病家族史比例45.95%(17/37)高于对照组[(2.41±0.74)mU/L、(3308.98±1942.65)IU/L、(2764.58±1804.57)IU/L、24.05%(38/158)]。回归结果显示血清TPO-Ab、TG-Ab、糖尿病家族史是GDM发生的影响因素(P<0.05);ROC曲线显示孕早期血清TPO-Ab、TG-Ab及联合检测GDM的AUC 95%CI分别为0.84(0.78,0.89)、0.80(0.74,0.86)、0.91(0.86,0.95),联合检测GDM的价值更高。结论孕早期血清TPO-Ab、TG-Ab是GDM发生的影响因素,血清TPO-Ab、TG-Ab及联合检测一定程度上可判断孕妇GDM发生风险,联合检测GDM的临床效能更高。 展开更多
关键词 糖尿病 妊娠 甲状腺球蛋白抗体(TG-Ab) 甲状腺过氧化物酶抗体(TPO-Ab) 孕早期 危险因素 预测
暂未订购
血清Tg、TgAb、ZEB1水平对甲状腺癌术后清甲治疗患者疾病复发的预测价值 被引量:3
20
作者 宋传伟 刘兆芳 刘兆琳 《陕西医学杂志》 2025年第6期825-829,851,共6页
目的:探讨血清甲状腺球蛋白(Tg)、甲状腺球蛋白抗体(TgAb)及E盒结合锌指蛋白1(ZEB1)水平对甲状腺癌术后清甲治疗患者疾病复发的预测价值。方法:选取实施甲状腺手术且术后接受清甲治疗随访5年出现复发的患者48例为复发组,选取年龄、性别... 目的:探讨血清甲状腺球蛋白(Tg)、甲状腺球蛋白抗体(TgAb)及E盒结合锌指蛋白1(ZEB1)水平对甲状腺癌术后清甲治疗患者疾病复发的预测价值。方法:选取实施甲状腺手术且术后接受清甲治疗随访5年出现复发的患者48例为复发组,选取年龄、性别基本匹配的同期术后清甲治疗且未发生复发的患者102例为对照组。比较两组患者清甲治疗后12个月Tg、TgAb、ZEB1 mRNA水平以及病理特征、^(131)I治疗情况,分析甲状腺癌术后清甲治疗患者疾病复发影响因素以及Tg、TgAb、ZEB1 mRNA水平对患者术后复发的预测价值。结果:复发组Tg、TgAb、ZEB1 mRNA水平高于对照组患者(均P<0.05)。复发组滤泡状癌、TNM分期Ⅲ-Ⅳ期、次全切手术、肿瘤直径≥5.0 cm、淋巴结转移、血管浸润、手术切缘阳性、24 h^(131)I摄取率<10%占比高于对照组(均P<0.05)。高Tg、高TgAb、高ZEB1 mRNA、滤泡状癌、TNM分期Ⅲ-Ⅳ期、手术次全切、淋巴结转移、24 h^(131)I摄取率<10%是甲状腺癌术后清甲治疗患者疾病复发的危险因素(均P<0.05)。Tg、TgAb、ZEB1 mRNA及三项联合预测甲状腺癌术后清甲治疗患者疾病复发的曲线下面积(AUC)分别为0.747、0.787、0.869、0.884。结论:血清Tg、TgAb、ZEB1 mRNA水平与甲状腺癌术后清甲治疗患者疾病复发关系密切,且三项联合对复发具有较高的预测价值。 展开更多
关键词 甲状腺癌 甲状腺球蛋白 甲状腺球蛋白抗体 E盒结合锌指蛋白1 复发 预测价值
暂未订购
上一页 1 2 49 下一页 到第
使用帮助 返回顶部